StockData
ALCNYSEOphthalmic GoodsFiscal year ends December 31

ALCON INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 24, 2026
$66.13−0.05 (-0.08%)

Close on Oct 19, 2026

Market cap
$32.32B
P/E (TTM)
33.4
Dividend yield
–

ALCON INC revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Surgical$5.75B$5.52B$5.31B$5.05B$4.70B$3.71B$4.17B$4.00B$3.74B55.3%+4.1%
Vision Care$4.57B$4.31B$4.06B$3.61B$3.52B$3.05B$3.19B$3.15B$3.06B43.9%+5.9%
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017YoY
Surgical$1.46B$1.47B$1.45B$1.34B–––––-0.5%
Vision Care$981.00M$962.00M$777.00M$600.00M–––––+2.0%

By product or service

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
International$5.66B$5.33B$5.06B$4.76B–––––54.4%+6.3%
United States$4.66B$4.51B$4.31B$3.90B–––––44.8%+3.2%
Rest of the world$4.41B$4.13B$3.89B$3.66B–––––42.4%+6.8%
Japan$609.00M$554.00M$583.00M$568.00M–––––5.9%+9.9%
China$570.00M$560.00M$526.00M$474.00M–––––5.5%+1.8%
Switzerland$71.00M$79.00M$64.00M$59.00M–––––0.7%-10.1%
International––$5.06B$4.76B$4.57B$3.79B$4.31B$4.21B$3.99B––

From the segment and revenue-disaggregation notes of Alcon's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.